Maryland HB679 prohibits health care practitioners from prescribing cross-sex hormone therapy for minors to treat gender dysphoria.
Maryland HB679 amends the Health Occupations Article to prohibit licensed health care practitioners from prescribing, dispensing, or administering cross-sex hormones, including estrogen, testosterone, or hormone blockers, to minors for treating gender dysphoria. This bill defines cross-sex hormones as those prescribed from an individual's assigned sex at birth to their experienced or expressed gender. Violators of this prohibition face felony charges and potential imprisonment.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.